BUCOLO, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 13.165
EU - Europa 7.785
AS - Asia 7.159
SA - Sud America 1.331
AF - Africa 876
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 10
Totale 30.342
Nazione #
US - Stati Uniti d'America 12.681
SG - Singapore 3.634
IT - Italia 2.224
RU - Federazione Russa 2.208
CN - Cina 1.931
BR - Brasile 1.119
IE - Irlanda 1.032
UA - Ucraina 863
VN - Vietnam 593
CI - Costa d'Avorio 405
CA - Canada 370
FR - Francia 359
DE - Germania 275
KR - Corea 231
GB - Regno Unito 172
NG - Nigeria 161
IN - India 145
SN - Senegal 145
SE - Svezia 127
FI - Finlandia 105
HK - Hong Kong 84
BD - Bangladesh 76
AR - Argentina 75
PL - Polonia 74
MX - Messico 72
ES - Italia 65
NL - Olanda 65
JP - Giappone 62
IQ - Iraq 59
ZA - Sudafrica 52
ID - Indonesia 51
CH - Svizzera 47
TR - Turchia 47
UZ - Uzbekistan 39
PK - Pakistan 33
EC - Ecuador 32
BE - Belgio 28
CO - Colombia 28
MA - Marocco 27
KE - Kenya 23
GR - Grecia 21
LT - Lituania 20
LB - Libano 19
VE - Venezuela 19
AE - Emirati Arabi Uniti 18
AT - Austria 18
BJ - Benin 16
CL - Cile 16
JO - Giordania 15
SA - Arabia Saudita 15
TN - Tunisia 15
PY - Paraguay 14
AU - Australia 13
IR - Iran 12
HR - Croazia 11
PH - Filippine 11
UY - Uruguay 11
CZ - Repubblica Ceca 10
PE - Perù 10
RO - Romania 10
EG - Egitto 9
EU - Europa 9
JM - Giamaica 9
AZ - Azerbaigian 8
DZ - Algeria 8
NP - Nepal 8
HN - Honduras 7
IL - Israele 7
SY - Repubblica araba siriana 7
DK - Danimarca 6
OM - Oman 6
PS - Palestinian Territory 6
PT - Portogallo 6
AL - Albania 5
BG - Bulgaria 5
BO - Bolivia 5
CR - Costa Rica 5
KZ - Kazakistan 5
MY - Malesia 5
RS - Serbia 5
CY - Cipro 4
ET - Etiopia 4
HU - Ungheria 4
KG - Kirghizistan 4
NI - Nicaragua 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
GD - Grenada 3
MD - Moldavia 3
MK - Macedonia 3
MN - Mongolia 3
TW - Taiwan 3
BB - Barbados 2
BH - Bahrain 2
CG - Congo 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
LV - Lettonia 2
MM - Myanmar 2
NO - Norvegia 2
Totale 30.302
Città #
Dallas 2.112
Singapore 2.112
Santa Clara 1.529
Chandler 1.160
Dublin 1.025
Moscow 905
Jacksonville 860
San Jose 791
Ashburn 684
Catania 623
Chicago 542
Boardman 442
Abidjan 405
Hefei 379
Nanjing 285
Lauterbourg 283
Lawrence 276
Cambridge 270
Andover 268
Beijing 268
Toronto 232
Seoul 228
Houston 219
Los Angeles 217
Ho Chi Minh City 199
Dakar 145
Des Moines 144
Hanoi 137
Council Bluffs 134
San Mateo 126
New York 123
Wilmington 119
São Paulo 101
Civitanova Marche 100
Buffalo 84
Rome 83
Grafing 82
Florence 76
Nanchang 76
Lagos 75
Hong Kong 74
Palermo 74
Orem 72
Abuja 71
Shenyang 69
Ottawa 67
Saint Petersburg 66
The Dalles 62
Hebei 61
Messina 56
Jiaxing 54
Warsaw 54
Bremen 53
Columbus 53
Tokyo 53
Rio de Janeiro 49
Changsha 47
Brooklyn 46
Lappeenranta 46
Tianjin 46
Montreal 41
Milan 39
Seattle 39
Munich 38
Denver 35
Aci Catena 34
Belo Horizonte 34
Johannesburg 31
London 31
Phoenix 31
Redwood City 31
San Francisco 31
Atlanta 29
Helsinki 29
Naples 29
Amsterdam 28
Dong Ket 27
Falls Church 27
Stockholm 27
Baghdad 25
Dearborn 25
Pune 25
Curitiba 24
Belpasso 23
Mexico City 23
Redondo Beach 23
Tashkent 23
Washington 23
Brussels 22
Hangzhou 22
Turku 22
Brasília 21
Jakarta 21
Ningbo 20
Pozzallo 20
Haiphong 19
Manchester 19
Boston 18
Guangzhou 18
Jinan 18
Totale 20.157
Nome #
A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice 286
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 277
Current drug treatments targeting dopamine D3 receptor 239
Dopaminergic-GABAergic interplay and alcohol binge drinking 232
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway 217
NAP modulates hyperglycemic–inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage 207
Cholesterol metabolites modulate ionotropic P2X4 and P2X7 receptor current in microglia cells 194
Antioxidant and osmoprotecting activity of taurine in dry eye models 190
A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptors 188
Carnosine decreases PMA-induced oxidative stress and inflammation in murine macrophages 186
Anti-VEGF agents inhibit activation of PLA2/COX-2 and expression of VEGF-A induced by high glucose, in human retinal pericytes in vitro 184
Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathway 182
Attenuation of High Glucose-Induced Damage in RPE Cells through p38 MAPK Signaling Pathway Inhibition 181
A new human blood–retinal barrier model based on endothelial cells, pericytes, and astrocytes 179
Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy 179
Purinergic ionotropic P2X7 and metabotropic glutamate mGlu5 receptors crosstalk influences pro-inflammatory conditions in microglia 178
Caffeine Protects Against Retinal Inflammation 178
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 176
Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3receptor blockade 175
Apixaban enhances vasodilatation mediated by protease-activated receptor 2 in isolated rat arteries 173
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 166
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 163
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 162
Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment 160
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 160
A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits 159
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 159
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model 158
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 158
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 155
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 152
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 151
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy 150
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 148
Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot Study 145
LATE-ONSET OCULAR HYPERTENSION AFTER VITRECTOMY: A Multicenter Study of 6,048 Eyes 144
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 142
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice 140
Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle-associated protein: Implications for diabetic retinopathy 139
Prognostic significance of deregulated microRNAs in uveal melanomas 139
Fluoxetine Protects Retinal Ischemic Damage in Mice 137
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 137
Epiretinal Membrane Vitrectomy With and Without Intraoperative Intravitreal Dexamethasone Implant: A Systematic Review With Meta-Analysis 137
A prolonged release polymeric nanocarrier for ocular administration 136
Carnosol attenuates high glucose damage in human retinal endothelial cells through regulation of ERK/Nrf2/HO-1 pathway 135
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 135
Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies 134
Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study 133
Controversies in Glaucoma: Current Medical Treatment and Drug Development 133
Acidic mammalian chitinase in dry eye conditions 132
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 132
Influence of trace elements on neurodegenerative diseases of the eye—the glaucoma model 131
Dihydrotanshinone, a natural diterpenoid, preserves blood-retinal barrier integrity via p2x7 receptor 131
Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation 130
Corneal wound healing and nerve regeneration by novel ophthalmic formulations based on cross-linked sodium hyaluronate, taurine, vitamin B6, and vitamin B12 129
Carnosine Counteracts the Molecular Alterations Aβ Oligomers-Induced in Human Retinal Pigment Epithelial Cells 129
Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological Mechanisms 129
Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage 129
Modulation of pro-oxidant and pro-inflammatory activities of m1 macrophages by the natural dipeptide carnosine 127
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 126
Pericyte-like differentiation of human adipose-derived mesenchymal stem cells: An in vitro study 126
Retinal Protection of New Nutraceutical Formulation 125
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 125
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 125
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 125
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 124
Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye 124
New Brilliant Blue G Derivative as Pharmacological Tool in Retinal Surgery 123
"In Vivo" Evaluation of Biocompatibility and Biodegradation of Different Hyaluronan Derivatives Intravitreal Implants with Ultrasound Biomicroscopy. 123
Retinal protection and distribution of curcumin in vitro and in vivo 122
Novel therapeutics in glaucoma management 121
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 121
Carnosine protects macrophages against the toxicity of aβ1-42 oligomers by decreasing oxidative stress 119
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa 118
Isolation, cultivation, and characterization of primary bovine cochlear pericytes: A new in vitro model of stria vascularis 118
MicroRNAs in the vitreous humor of patients with retinal detachment and a different grading of proliferative vitreoretinopathy: A pilot study 118
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology 117
Acidic Mammalian chitinase and the eye: implications for ocular inflammatory diseases. 117
Drug-Repurposing Strategy for Dimethyl Fumarate 116
P2X7 receptor antagonism: implications in diabetic retinopathy 115
Ocular pharmacological profile of hydrocortisone in dry eye disease 114
Do extracellular RNAs provide insight into uveal melanoma biology? 114
PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina 113
Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution 113
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 113
Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets? 112
From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma 111
Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells 111
The immune system on the TRAIL of Alzheimer’s disease 111
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 110
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 110
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 109
Davunetide (NAP) Protects the Retina Against Early Diabetic Injury by Reducing Apoptotic Death 109
Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review 108
Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration 108
Rapid determination of nimesulide in rabbit aqueous humor by liquid chromatography 106
Effects of Cloricromene, a Coumarin Derivative, on Rabbit Dry Eye Model 106
Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies 106
Editorial: Ocular Pharmacology: Recent Breakthroughs and Unmet Needs 106
Ruolo fisiologico del monossido d’azoto e monossido di carbonio nella modulazione della pressione endoculare 105
Totale 14.310
Categoria #
all - tutte 99.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.363


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021323 0 0 0 0 0 0 0 0 0 43 186 94
2021/20222.151 242 278 44 32 305 58 318 92 210 38 71 463
2022/20233.666 317 175 54 374 395 598 37 617 858 46 131 64
2023/20241.588 117 230 87 106 83 326 27 118 12 25 276 181
2024/20256.437 81 997 324 319 1.341 725 324 274 552 573 464 463
2025/202612.895 811 735 2.465 856 2.030 2.575 1.604 342 707 770 0 0
Totale 30.923